Motif ID: TCF21
Z-value: 1.454
Transcription factors associated with TCF21:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
TCF21 | ENSG00000118526.6 | TCF21 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TCF21 | hg19_v2_chr6_+_134210243_134210276 | 0.03 | 8.9e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.5 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
1.7 | 5.0 | GO:0048627 | myoblast development(GO:0048627) |
1.4 | 4.1 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.2 | 6.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.2 | 7.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
1.2 | 9.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
1.1 | 3.3 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
1.0 | 3.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.8 | 2.5 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
0.8 | 3.3 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.7 | 4.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 1.6 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 2.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.4 | 1.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) cellular alkene metabolic process(GO:0043449) |
0.4 | 1.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 2.1 | GO:0035803 | egg coat formation(GO:0035803) |
0.3 | 1.3 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.3 | 1.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 4.7 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.3 | 2.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.9 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.3 | 3.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 1.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 1.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 0.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 1.0 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 1.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.7 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.2 | 1.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 0.7 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.2 | 2.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 0.8 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.2 | 0.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.2 | 1.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.2 | 0.7 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.2 | 0.5 | GO:0019085 | early viral transcription(GO:0019085) |
0.2 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.6 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.1 | 0.7 | GO:0048749 | compound eye development(GO:0048749) |
0.1 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 1.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 1.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.7 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 0.6 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 1.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 1.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 0.5 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 2.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.3 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.1 | 1.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 3.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.9 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.1 | 0.6 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 0.3 | GO:0040010 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.1 | 0.8 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.7 | GO:0002326 | B cell lineage commitment(GO:0002326) immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.2 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 0.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.4 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 1.6 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 1.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.2 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.1 | 0.5 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.3 | GO:0071469 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
0.1 | 0.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 1.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 2.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.3 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.1 | 3.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 2.3 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.7 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 1.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 2.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.2 | GO:1904647 | response to rotenone(GO:1904647) |
0.1 | 0.2 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.8 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 1.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.2 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 1.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.9 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.2 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.0 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 1.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 1.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 1.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 3.0 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
0.0 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.0 | 0.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 1.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 1.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.0 | 0.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 1.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.7 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.0 | 1.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 1.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 3.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.2 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.0 | 1.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 1.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.0 | 0.3 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.6 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:1901804 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 3.9 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 1.8 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 1.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 1.5 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.0 | 1.9 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.0 | 1.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.8 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 2.7 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.0 | 0.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.0 | 0.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.0 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.0 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 1.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.5 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.5 | GO:2000816 | negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.0 | 1.7 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.2 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.3 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.2 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.3 | GO:0030866 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 2.9 | GO:0007015 | actin filament organization(GO:0007015) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 7.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
1.4 | 4.1 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.6 | 12.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.6 | 2.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 2.1 | GO:0031905 | early endosome lumen(GO:0031905) |
0.4 | 3.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 3.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.2 | 1.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 2.6 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 1.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.9 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 1.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 6.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 1.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 2.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 6.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 7.1 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 2.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 1.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 4.9 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.6 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 2.3 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 9.1 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 2.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.0 | 3.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.8 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 1.3 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 1.5 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 6.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 3.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 1.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.5 | GO:0097546 | mediator complex(GO:0016592) ciliary base(GO:0097546) |
0.0 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 1.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 1.5 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.2 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 2.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.8 | GO:0030395 | lactose binding(GO:0030395) |
1.4 | 4.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.2 | 7.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
1.1 | 7.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.9 | 4.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.7 | 4.0 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.6 | 1.3 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.6 | 3.0 | GO:0032810 | sterol response element binding(GO:0032810) |
0.5 | 3.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 2.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 2.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.5 | 2.1 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.4 | 3.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 1.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.3 | 1.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 2.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 2.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 0.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.7 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.2 | 0.7 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.2 | 2.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.7 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.2 | 0.5 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 0.3 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.1 | 1.0 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.1 | 14.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 4.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 0.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.3 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 0.3 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.1 | 1.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.3 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.1 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 2.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.2 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 1.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 1.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 1.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 2.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 1.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 3.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 3.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.0 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 2.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.0 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 1.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.9 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 1.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 1.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 1.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 1.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.0 | 1.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 1.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 1.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.4 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 1.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 2.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 1.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 3.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.7 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 7.1 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 12.6 | PID_PLK1_PATHWAY | PLK1 signaling events |
0.1 | 3.1 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 6.9 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.1 | 3.8 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.1 | 2.5 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.7 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.2 | PID_ATR_PATHWAY | ATR signaling pathway |
0.0 | 2.4 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 2.7 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.5 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
0.0 | 2.0 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.9 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.7 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.0 | 1.5 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.0 | 1.2 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.5 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
0.0 | 0.6 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.5 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.6 | PID_AURORA_A_PATHWAY | Aurora A signaling |
0.0 | 0.3 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.0 | PID_LYSOPHOSPHOLIPID_PATHWAY | LPA receptor mediated events |
0.0 | 0.5 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.6 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
0.0 | 1.0 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
0.0 | 0.8 | PID_SHP2_PATHWAY | SHP2 signaling |
0.0 | 0.7 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.5 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
0.0 | 0.3 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.0 | 3.2 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 14.6 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 5.2 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 4.0 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
0.2 | 12.4 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.4 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
0.1 | 5.0 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
0.1 | 4.7 | REACTOME_KINESINS | Genes involved in Kinesins |
0.1 | 2.2 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 7.2 | REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.9 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.1 | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.3 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.3 | REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.2 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
0.1 | 0.7 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.9 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.1 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
0.0 | 2.3 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.5 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.9 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.9 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.7 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 2.3 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 3.6 | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 1.1 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.6 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 2.5 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.2 | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.9 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.8 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 3.1 | REACTOME_CELL_JUNCTION_ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 1.2 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.6 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 3.0 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.2 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 1.0 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
0.0 | 1.9 | REACTOME_OLFACTORY_SIGNALING_PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.7 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.5 | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.3 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.7 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 3.6 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.7 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.7 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.7 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.5 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.4 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.2 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.1 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.4 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.6 | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 1.4 | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |